AWS partners on lab‑in‑loop app

Drug discovery is getting a new kind of software middleman: Amazon Web Services on April 14 launched Amazon Bio Discovery to link artificial intelligence design tools with real lab testing. (aboutamazon.com) In drug research, scientists first design a candidate molecule on computers, then send it to a wet lab for synthesis and testing, then feed the results back into the next round. Amazon Web Services said its new application wraps those steps into one system and lets researchers run workflows without writing code. (aws.amazon.com) (usnews.com) Amazon Web Services said the software gives researchers access to more than 40 biological artificial intelligence models, plus tools to bring in their own proprietary models and data. The company also listed Ginkgo Bioworks, Twist Bioscience, and A-Alpha Bio as contract research organization partners for wet-lab validation. (aws.amazon.com) The system uses what Amazon Web Services calls an agent, a software assistant that helps choose models, set inputs, and score results for experiments. The company said that is meant to reduce reliance on computational biologists, who often act as the bottleneck between bench scientists and machine-learning tools. (aboutamazon.com) (aws.amazon.com) That matters because many biology teams already have strong prediction models, but the handoff from computer output to lab work is still fragmented across vendors, data systems, and procurement steps. Amazon Web Services said Amazon Bio Discovery routes selected candidates directly to lab partners and sends test results back into the same workflow for the next iteration. (aboutamazon.com) (genengnews.com) Amazon Web Services tied the launch to antibody discovery, where researchers search huge numbers of protein designs for a small set worth making and testing. On its resource page, the company highlighted an April 2026 workflow that generated 288,000 nanobody designs, narrowed them to 100,000 candidates for screening, and found 46 of 116 tested candidates with reliable kinetic fits. (aws.amazon.com) The company also pointed to work with Memorial Sloan Kettering, saying the application cut antibody design for potential pediatric cancer therapies from months to weeks. Reuters reported the product is aimed at early-stage drug discovery, where drugmakers and technology companies have been pushing to use artificial intelligence to shorten research timelines. (aboutamazon.com) (tech.yahoo.com) Ginkgo and Twist bring the physical side of that loop. Twist sells synthetic DNA and antibody-discovery tools, while Ginkgo runs large-scale biological research and automation systems and has used Amazon Web Services infrastructure since migrating workloads in 2019. (twistbioscience.com) (aws.amazon.com) Amazon Web Services has been signaling this direction for months. At its 2025 Life Sciences Symposium, the company said customers were using autonomous artificial intelligence agents, biology foundation models, and lab-in-the-loop systems to accelerate drug discovery. (aws.amazon.com) The immediate test is whether drug researchers treat Amazon Bio Discovery as another model catalog or as the operating layer between software and the lab bench. Amazon Web Services has now put Ginkgo and Twist inside that loop from day one. (aws.amazon.com)